Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms.

待确认 10 由没烦恼的圆嘟嘟发布于 2026/4/10 9:42:35

DOI:10.2174/0113816128328422240820105654
作者：Yaning Lyu,?Xifeng Liang,?Shuang Gao,?Jing Li,?Jinming Li,?Shuhan Zhang,?Chenghong Yin,?Cheng Chi
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.2174/0113816128328422240820105654

Bentham Science

Abstract：Background: Compound 861 (Cpd861) is a traditional Chinese herbal compound for the treatment of hepatic fibrosis (HF). In the current investigation, Cpd861 has been demonstrated to have an u

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

13小时前

龟小乌

f669f472347f11f199b834735aa3bc31.pdf

14小时前

Book学术机器人

2026/4/10 9:42:35 未找到该文献，机器人已退出，请等待人工下载

2026/4/10 9:42:35 Book学术AI机器人收到请求，开始寻找文献

2026/4/10 9:42:35 已向机器人发送请求

14小时前

没烦恼的圆嘟嘟发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierERBB2 activating mutations and co-occurring genomic alterations contribute to disease heterogeneity in patients with ERBB2-mutant lung cancer.